CRT 2024
CardioTube Interview
Spencer B. King, III, MD, MACC, MSCAI
Professor of Medicine Emeritus
Emory University
Atlanta, Georgia, United States
No relationships to disclose
S. Jay Mathews, MD
Director, Cardiac Cath Lab, PERT, & Structural Heart
Manatee Memorial Hospital
Disclosure(s): Abbott: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Akura Medical: Consultant/Advisory Board (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Bolt Medical: Consultant/Advisory Board (Ongoing); Boston Scientific: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Cardiva: Consultant (Ongoing), Speakers' Bureau (Ongoing); CONTEGO MEDICAL: Clinical Trial Support (Ongoing), Consultant/Advisory Board (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Cordis, Endovascular Division: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Endologix: Consultant (Ongoing); Evident Vascular: Consultant/Advisory Board (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Innova vascular: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Inquis: Consultant (Ongoing); Penumbra, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speakers' Bureau (Ongoing); Philips Medical: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speakers' Bureau (Ongoing); Protexa: Advisory Committee/Board Member (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Reflow Medical: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Shockwave: Consultant (Ongoing), Speakers' Bureau (Ongoing)